Current Opinion in Pulmonary Medicine

Article	Citations
Obstructive lung diseases burden and COVID-19 in developing countries: a perspective	65
Drug-induced sarcoidosis-like reactions	35
Drug-resistant tuberculosis: advances in diagnosis and management	29
Activity-related dyspnea and exercise intolerance in chronic obstructive pulmonary disease: recent insights	26
Advances in bronchoscopic optical coherence tomography and confocal laser endomicroscopy in pulmonary diseases	25
A clinical review of long-COVID with a focus on the respiratory system	24
Home monitoring in asthma: towards digital twins	24
Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment	22
Sarcoidosis and maligancy: the chicken and the egg?	22
Therapeutic bronchoscopy for malignant central airway obstruction: impact on quality of life and risk-benefit analysis	22
Respiratory viral infections in the immunocompromised	21
Current hot topics in pulmonary hypertension	20
Progress in the radiologic diagnosis of idiopathic pulmonary fibrosis	18
Big data in sarcoidosis	18
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	17
Hit-hard and early versus step-up treatment in severe sarcoidosis	17
The prognostic relevance of exercise pulmonary hypertension in cardiac and pulmonary diseases	17
Robotic bronchoscopy for peripheral pulmonary lesions: a convergence of technologies	16
Thoracic computed tomography in the progressive fibrotic phenotype	16
Bacteriophages for bronchiectasis: treatment of the future?	16
Cyclic alternating patterns and arousals: what is relevant in obstructive sleep apnea? In Memoriam Mario Giovanni Terzano	16
Labelling and denominating lung toxicity effects of pesticides	16
Obesity-related asthma: new insights leading to a different approach	16
Keeping global focus on the many challenges of respiratory tract infections	15
Organ involvement and assessment in sarcoidosis	14

Patterns of progression in non-IPF fibrotic interstitial lung disease	14
Gram-negative pulmonary infections – advances in epidemiology and diagnosis	14
Editorial introductions	13
Update on the genetic basis of obstructive sleep apnoea – hype or hope?	13
Epidemiology and real-life experience in progressive pulmonary fibrosis	12
Bronchoscopic interventions for chronic bronchitis	12
Senescence in pulmonary arterial hypertension: is there a link?	12
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	12
Editorial: COPD in the COVID-19 era, challenging concepts and developments in COPD, and occupational exposures and susceptibilities	12
Editorial: Pesticides and lung function	11
The persistent problem of persistent air-leaks: approach to management	11
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	11
Editorial introductions	11
Drug treatment of COVID-19 infection	11
Bronchoscopic treatment of early-stage peripheral lung cancer	11
Editorial: Are we ready for prime time?	11
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	11
Selected updates on chronic obstructive pulmonary disease	11
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	10
Evidence from recent clinical trials in fibrotic interstitial lung diseases	10
Outcomes of lung transplantation in cystic fibrosis	10
The evolving role of radiological imaging in cystic fibrosis	9
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	9
Treatment strategies for malignant pulmonary nodule: beyond lobectomy. Point-counterpoint	9
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	9
The role of PET in the management of sarcoidosis	9
Interstitial lung disease following coronavirus disease 2019	9
Effectiveness and safety of coronavirus disease 2019 vaccines	9
Exhaled breath analysis in interstitial lung disease	9
Novel insights in fibrotic pulmonary sarcoidosis	9
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	8
Management of pneumothorax: an update	8
COVID-19 and other respiratory tract infections at mass gathering religious and sporting events	8
Syndromic genetic causes of pulmonary fibrosis	8
Severe pulmonary toxicity associated with inhalation of pyrethroid-based domestic insecticides (Bop/Sapolio): a case series and literature review	8
Digital outcome measures in pulmonary clinical trials	8
Lung microbiome, gut–lung axis and chronic obstructive pulmonary disease	8
Sarcoidosis associated pulmonary hypertension: an update	8
Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease	7
Training in interventional pulmonology: a leap into the future	7
Diagnosis of invasive respiratory mycoses in the immunocompromised host	7
Editorial introductions	7
Role of biomarkers in lung nodule evaluation	7
Infection control in cystic fibrosis: evolving perspectives and challenges	7
Chronic obstructive pulmonary disease and obstructive sleep apnoea overlap: co-existence, co-morbidity, or causality?	7
An update on bronchopleural fistulae following cancer-related surgery	7
Altered pharmacology and toxicology during ageing: implications for lung disease	7
Nonpharmaceutical interventions for managing SARS-CoV-2	7
What is new in mediastinal staging?	6
Improving care in lung cancer surgery: a review of quality measures and evolving standards	6

The evolving paradigm of precision medicine in lung cancer	6
How do we expand the lung donor pool?	6
Direct oral anticoagulant use in special populations	6
Editorial introductions	6
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	6
Editorial: Endobronchial valve placement for endoscopic lung volume reduction (ELVR): “the start of a new era”	6
The lung way home: ready for home monitoring in lung diseases?	6
Pediatric sarcoidosis with diagnostic and therapeutical insights	6
Transbronchial biopsy vs. bronchoalveolar lavage in interstitial lung disease	6
Editorial: The role of ageing in pulmonary disease	6
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	6
Editorial: COVID pandemic and Lung cancer: challenges lead to opportunities	6
At a crossroads: coronavirus disease 2019 recovery and the risk of pulmonary vascular disease	6
The justification for the progressive fibrotic phenotype	6
Biopsy in interstitial lung disease: specific diagnosis and the identification of the progressive fibrotic phenotype	6
Telerehabilitation in pulmonary diseases	5
Editorial: Sarcoidosis: now and into the future	5
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	5
Multidisciplinary care in nonmalignant central airway obstruction	5
Transbronchial lung cryobiopsy for the diagnosis of interstitial lung diseases	5
Nutritional and metabolic management for cystic fibrosis in a post-cystic fibrosis transmembrane conductance modulator era	5
Epigenetics and aging: relevance for sleep medicine	5
Competency-based medical education in interventional pulmonology: current state and future opportunities	5
Risk stratification of indeterminate pulmonary nodules	5
The different facets of sickle cell disease-related pulmonary hypertension	5
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges	5
Bronchodilator responsiveness in chronic obstructive pulmonary disease: prevalence, significance, and clinical implications	5
Right ventricular assessment in pulmonary hypertension	4
Asthma diagnosis using patient-reported outcome measures and objective diagnostic tests: now and into the future	4
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	4
Silica-associated lung disease in developing countries	4
The association of preexisting severe asthma with COVID-19 outcomes	4
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	4
Implementation of digital home monitoring and management of respiratory disease	4
Influenza: clinical aspects, diagnosis, and treatment	4
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	4
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	4
Drug-induced comorbidities in patients with sarcoidosis	4
Group 2 pulmonary hypertension: from diagnosis to treatment	4
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	4
Indwelling pleural catheters for benign pleural effusions: a concise review	4
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus	4
Advances in inhaled antibiotics for management of respiratory tract infections	4
Genetics in sarcoidosis	4
Interstitial lung disease-associated pulmonary hypertension – what the future holds	4
Accuracy of respiratory event indices downloaded from positive airway pressure devices: can they be relied upon when making treatment decisions?	4
Editorial: ‘What is your occupation?’: historical snippets	3
Mild airways obstruction: spirometric diagnostic pitfalls and solutions	3
Disparities across the continuum of lung cancer care: a review of recent literature	3
Telemedicine and home monitoring for COPD – a narrative review of recent literature	3
Use of biologics for the treatment of moderate-to-severe asthma: the age of personalized medicine	3
Tuberculous pleuritis: clinical presentations and diagnostic challenges	3
Adenotonsillectomy: the good, the bad and the unknown	3
The changing landscape of infections in the lung transplant recipient	3
Upper airway muscles: influence on obstructive sleep apnoea pathophysiology and pharmacological and technical treatment options	3
Editorial: Advancements in asthma diagnosis and management: what's new?	3
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH	3
Update in approaches to pulmonary hypertension because of left heart disease	3
Occupational exposures and sarcoidosis: current understanding and knowledge gaps	3
Disease-specific gaps within fungal respiratory tract infections: clinical features, diagnosis, and management in critically ill patients	3
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	3
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	3
The current understanding and future directions for sputum microbiome profiling in chronic obstructive pulmonary disease	3
Detection of early phenotype cardiac sarcoidosis by cardiovascular magnetic resonance	3
Telehealth and virtual health monitoring in cystic fibrosis	3
Environmental and occupational exposures in interstitial lung disease	3
Lung infections due to emerging fungal pathogens	3
Anesthetic considerations in interventional pulmonology	3
Candidate selection for lung transplantation – considerations beyond the medical evidence	3
Editorial introductions	3
Risk stratification of pulmonary embolism	2
Prader–Willi syndrome: an update	2
Recent advances in the management of systemic sclerosis-associated interstitial lung disease	2
Scleroderma pulmonary arterial hypertension: the same as idiopathic pulmonary arterial hypertension?	2
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	2
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	2
Recent developments in occupational asthma	2
Emerging clinical perspectives in cystic fibrosis liver disease	2
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	2
Quantitative computed tomography and machine learning: recent data in fibrotic interstitial lung disease and potential role in pulmonary sarcoidosis	2

Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	2
Management of complicated parapneumonic effusions	2
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	2
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	2
Pleuroparenchymal fibroelastosis	2
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	2
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	2
Sleep in the intensive care unit	2
Current challenges and perspectives in lung cancer care during COVID-19 waves	2
Eosinophilic respiratory disorders and the impact of biologics	2
Breath of fresh insight: unraveling the evolution of our understanding of cystic fibrosis pulmonary exacerbations	2
Noninvasive positive pressure in acute exacerbations of chronic obstructive pulmonary disease	2
Editorial introductions	2
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	2
Bronchoscopic diagnosis of peripheral lung lesions	2
Postpulmonary embolism syndrome	2
Endobronchial treatment of severe asthma and severe emphysema with hyperinflation	2
Whole lung lavage: considerations from the anesthesiology perspective	1
Palliative care in advanced pulmonary fibrosis	1
COVID-19 infection in patients with sarcoidosis: susceptibility and clinical outcomes	1
Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2	1
The role of oscillometry in asthma	1
Editorial introduction	1
Lung abscess: an update on the current knowledge and call for future investigations	1
Editorial introductions	1
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?	1
Toward targeted treatments for silicosis	1
Transcutaneous electrical stimulation in obstructive sleep apnoea: current developments and concepts of the TESLA-home programme	1
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	1
Interstitial pneumonia with autoimmune features: from research classification to diagnosis	1
Metabolics of PH – an update	1
Considerations and clinical management of infections in sarcoidosis	1
Military deployment-related respiratory problems: an update	1
Editorial introductions	1
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	1
The evolving role of medical thoracoscopy on therapeutic management of pleural disease	1
Pulmonary vascular diseases at high altitude – is it safe to live in the mountains?	1
Lung transplant referral considerations for individuals with cystic fibrosis	1
As-needed inhaled corticosteroids as add-on therapy versus SMART therapy: an evolving understanding of the two approaches in the management of moderate-to-severe asthma	1
Asthma guidelines: comparison of the National Heart, Lung, and Blood Institute Expert Panel Report 4 with Global Initiative for Asthma 2021	1
Editorial introductions	1
Editorial introductions	1
Editorial introductions	1
COVID-19: vaccines, efficacy and effects on variants	1
Updates in the use of cannabis for insomnia	1
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	1
Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic	1
The progressive fibrotic phenotype in current clinical practice	1
Nontuberculous mycobacteria in cystic fibrosis	1
Ageing and chronic obstructive pulmonary disease: interrelationships	1
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions	1
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	1
Advancing bacteriophages as a treatment of antibiotic-resistant bacterial pulmonary infections	1
Ergonomics in bronchoscopy	1
The bronchiectasis microbiome: current understanding and treatment implications	1
Recent advances in the genetics of idiopathic pulmonary fibrosis	1
Current state and future potential of AI in occupational respiratory medicine	1
Advancements in airway stents: a comprehensive update	1
Editorial: A future focus on cystic fibrosis in an era of uncertainty despite opportunity	1
Asthma in pregnancy: a review of recent literature	1
Editorial introductions	1
Editorial: The evolving landscape of asthma: recent advances and challenges	1
Paediatric asthma - all that wheezes is not necessarily asthma - current diagnostic and management strategies	1
Management of fibrotic hypersensitivity pneumonitis	1
Shifting gears: the search for group 3 pulmonary hypertension treatment	1
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	1
Long-term safety, durability of response, cessation and switching of biologics	1
The role of primary care in sarcoidosis	1
Asbestos-associated pulmonary disease	1
Hypoxic burden – definitions, pathophysiological concepts, methods of evaluation, and clinical relevance	1
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	1